Nomegestrol acetate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Nomegestrol acetate
Accession Number
DB13981
Description

Nomegestrol acetate, also known as NOMAC, is a progestin used in oral contraceptives, menopausal hormone therapy, and for the treatment of gynecological disorders.

Type
Small Molecule
Groups
Investigational
Structure
Thumb
Weight
Average: 370.489
Monoisotopic: 370.214409446
Chemical Formula
C23H30O4
Synonyms
  • 17-alpha-Acetoxy-6-methyl-19-nor-4,6-pregnadiene-3,20-dione
  • 17-alpha-Hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione acetate
External IDs
  • ORG 10486-0
  • ORG-10486-0
  • TX 066
  • TX-066

Pharmacology

Indication
Not Available
Associated Conditions
Associated Therapies
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbametapirThe serum concentration of Nomegestrol acetate can be increased when it is combined with Abametapir.
AbciximabNomegestrol acetate may decrease the anticoagulant activities of Abciximab.
AcenocoumarolThe therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Nomegestrol acetate.
AcetaminophenThe metabolism of Nomegestrol acetate can be increased when combined with Acetaminophen.
AcetazolamideThe metabolism of Nomegestrol acetate can be increased when combined with Acetazolamide.
AcetohexamideThe therapeutic efficacy of Acetohexamide can be decreased when used in combination with Nomegestrol acetate.
Acetylsalicylic acidNomegestrol acetate may decrease the anticoagulant activities of Acetylsalicylic acid.
AcitretinThe therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Acitretin.
AlitretinoinThe therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Alitretinoin.
AlpelisibThe metabolism of Nomegestrol acetate can be increased when combined with Alpelisib.
Additional Data Available
  • Extended Description
    Extended Description
    Available for Purchase

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity
    Available for Purchase

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level
    Available for Purchase

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action
    Available for Purchase

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Purchasing individual compounds or compound libraries for your research?
Learn More

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety.
Kingdom
Organic compounds
Super Class
Lipids and lipid-like molecules
Class
Steroids and steroid derivatives
Sub Class
Pregnane steroids
Direct Parent
Gluco/mineralocorticoids, progestogins and derivatives
Alternative Parents
Steroid esters / 20-oxosteroids / 3-oxosteroids / Cyclohexenones / Alpha-acyloxy ketones / Carboxylic acid esters / Monocarboxylic acids and derivatives / Organic oxides / Hydrocarbon derivatives
Substituents
20-oxosteroid / 3-oxosteroid / Aliphatic homopolycyclic compound / Alpha-acyloxy ketone / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Cyclic ketone / Cyclohexenone / Hydrocarbon derivative
Molecular Framework
Aliphatic homopolycyclic compounds
External Descriptors
Not Available

Chemical Identifiers

UNII
83J78V5W05
CAS number
58652-20-3
InChI Key
IIVBFTNIGYRNQY-YQLZSBIMSA-N
InChI
InChI=1S/C23H30O4/c1-13-11-20-18(17-6-5-16(26)12-19(13)17)7-9-22(4)21(20)8-10-23(22,14(2)24)27-15(3)25/h11-12,17-18,20-21H,5-10H2,1-4H3/t17-,18-,20-,21+,22+,23+/m1/s1
IUPAC Name
(1R,3aS,3bS,9aR,9bS,11aS)-1-acetyl-5,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate
SMILES
[H][[email protected]@]12CC[[email protected]](OC(C)=O)(C(C)=O)[[email protected]@]1(C)CC[[email protected]]1([H])[[email protected]@]3([H])CCC(=O)C=C3C(C)=C[[email protected]@]21[H]

References

General References
  1. EMC Summary of Product Characteristics: Zoely (nomegestrol acetate/estradiol) oral tablets [Link]
  2. AIFA Product Information: Lutenyl (nomegestrol acetate) oral tablets [Link]
KEGG Drug
D08281
ChemSpider
82771
RxNav
53744
ChEBI
135564
ChEMBL
CHEMBL1476022
ZINC
ZINC000003938628
Wikipedia
Nomegestrol_acetate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4TerminatedScreeningContraception / Hypercoagulability1
3CompletedPreventionContraception1
3TerminatedPreventionContraception1
3Unknown StatusTreatmentDisseminated Sclerosis1
3WithdrawnTreatmentContraception1
2CompletedTreatmentContraception1
2CompletedTreatmentMenstrual Cramps1
1CompletedNot AvailableContraception1
1CompletedOtherHealthy Volunteers1
1WithdrawnBasic ScienceBioequivalence1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, coatedOral1.5 mg
TabletOral5 MG
TabletOral1.5 MG
Tablet, coatedOral2.5 mg
Tablet, film coatedOral2.5 mg
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00415 mg/mLALOGPS
logP3.46ALOGPS
logP3.42ChemAxon
logS-5ALOGPS
pKa (Strongest Acidic)17.72ChemAxon
pKa (Strongest Basic)-4.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area60.44 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity104.18 m3·mol-1ChemAxon
Polarizability41.78 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Enzymes

Kind
Protein
Organism
Humans
Pharmacological action
No
Actions
Substrate
General Function
Vitamin d3 25-hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation react...
Gene Name
CYP3A4
Uniprot ID
P08684
Uniprot Name
Cytochrome P450 3A4
Molecular Weight
57342.67 Da
References
  1. Binkowska M, Woron J: Progestogens in menopausal hormone therapy. Prz Menopauzalny. 2015 Jun;14(2):134-43. doi: 10.5114/pm.2015.52154. Epub 2015 Jun 22. [PubMed:26327902]

Drug created on January 20, 2018 08:25 / Updated on October 15, 2020 21:34

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates